Bajaj Healthcare Limited - Asset Resilience Ratio

Latest as of March 2026: 0.65%

Bajaj Healthcare Limited (BAJAJHCARE) has an Asset Resilience Ratio of 0.65% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check BAJAJHCARE strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs59.79 Million
≈ $646.56K USD Cash + Short-term Investments

Total Assets

Rs9.23 Billion
≈ $99.84 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2026)

This chart shows how Bajaj Healthcare Limited's Asset Resilience Ratio has changed over time. See Bajaj Healthcare Limited (BAJAJHCARE) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Bajaj Healthcare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BAJAJHCARE market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs59.79 Million 0.65%
Total Liquid Assets Rs59.79 Million 0.65%

Asset Resilience Insights

  • Limited Liquidity: Bajaj Healthcare Limited maintains only 0.65% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Bajaj Healthcare Limited Industry Peers by Asset Resilience Ratio

Compare Bajaj Healthcare Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
Drug Manufacturers - Specialty & Generic 0.35%
Bausch Health Companies Inc
TO:BHC
Drug Manufacturers - Specialty & Generic 4.97%
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
Drug Manufacturers - Specialty & Generic 24.59%
Curaleaf Holdings Inc.
TO:CURA
Drug Manufacturers - Specialty & Generic 3.73%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
China Animal Husbandry Industry Co Ltd
SHG:600195
Drug Manufacturers - Specialty & Generic 3.81%

Annual Asset Resilience Ratio for Bajaj Healthcare Limited (2015–2026)

The table below shows the annual Asset Resilience Ratio data for Bajaj Healthcare Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 0.65% Rs59.79 Million
≈ $646.56K
Rs9.23 Billion
≈ $99.84 Million
+0.43pp
2025-03-31 0.22% Rs18.47 Million
≈ $199.75K
Rs8.33 Billion
≈ $90.09 Million
+0.12pp
2024-03-31 0.10% Rs7.54 Million
≈ $81.55K
Rs7.65 Billion
≈ $82.75 Million
-0.07pp
2023-03-31 0.17% Rs15.09 Million
≈ $163.17K
Rs9.01 Billion
≈ $97.49 Million
-1.36pp
2022-03-31 1.53% Rs110.16 Million
≈ $1.19 Million
Rs7.21 Billion
≈ $77.98 Million
+1.40pp
2021-03-31 0.13% Rs6.63 Million
≈ $71.73K
Rs5.26 Billion
≈ $56.85 Million
+0.13pp
2020-03-31 0.00% Rs-375.00
≈ $-4.06
Rs3.26 Billion
≈ $35.23 Million
0.00pp
2015-03-31 0.00% Rs375.00
≈ $4.06
Rs1.46 Billion
≈ $15.77 Million
--
pp = percentage points

About Bajaj Healthcare Limited

NSE:BAJAJHCARE India Drug Manufacturers - Specialty & Generic
Market Cap
$110.69 Million
Rs10.24 Billion INR
Market Cap Rank
#18796 Global
#1013 in India
Share Price
Rs304.05
Change (1 day)
-2.17%
52-Week Range
Rs274.95 - Rs534.60
All Time High
Rs712.20
About

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more